RMC No. 62-2025 — Publishing the full text of the May 15, 2025 Letter from the Food and Drug Administration of the Department of Health endorsing updates to the List of VAT-Exempt Products Under RA No. 10963 (TRAIN Law) and RA No. 11534 (CREATE Act) Digest | Full Text | Annex A

BUREAU OF INTERNALREVENUE REPUBLIC OF THE PHILIPPINES DEPARTMENT OF FINANCE

Bringing In Revenues for Nation-Building PILIPINAS BAGONG

JUN 2 0 2025

REVENUE MEMORANDUM CIRCULAR NO._ 0 6 2 - 2 0 2 5

SUBJECT :Publishing the Full Text of the May 15, 2025 Letter from the Food and Drug Updates to the List of VAT-Exempt Products Under Republic Act (R.A. Administration (FDA) of the Department of Health OH Endorsing

No.10963 (TRAIN Law) and R.A.No.11534(CREATE Act)

TO :All Internal Revenue Officers and Others Concerned

For the information and guidance of all internal revenue officers, employees and others concerned,attached is the May 15,2025 letterAnnexA)from Atty.Paolo S.Teston,Director

No. 11534 or the CREATE Act, particularly the following: General of the FDA, for an update to the published List of VAT-Exempt Medicines under R.A.

1.Inclusion of certain medicines for cancer, diabetes, high cholesterol, hypertension

and mental diseases tuberculosis; and

2. Deletion of certain medicine for cancer.

As clarified under Q&A No. 1 of RMC No.99-2021,the effectivity of the VAT exemption of the covered medicines and medical devices under the CREATE Act shall be on the date of publication by the FDA of the updates to the said list.

All concerned are hereby enjoined to be guided accordingly and give this Circular as wide a publicity as possible

ROMF WGUI, JR. BUREAUOFINTERNALREVENUE ECC MANAGEMENT DIVISION Cor missioner of Internal Revenue

JUN 2 0 2025

BY ADMINUNIT ON TIME: 4:10

BIR National Office Bldg.,Senator Miriam Defensor-Santiago Avenue,Diliman,Quezon City Trunkline:8981-7000;8929-7676 Website: www.bir.gov.ph